Uniswap (UNI) is gaining attention from both retail and institutional investors. The UNI is experiencing a rally based on strong price momentum and a recent filing by investment firm Bitwise for a spot exchange-traded fund (ETF) on Uniswap’s (UNI) token with the United States Securities and Exchange Commission (SEC).
At press time, UNI is trading at $3.53, with a 24-hour trading volume of $810.09 million and a market capitalization of $2.25 billion, according to CoinMarketCap. Over the past 24 hours, UNI’s price surged 7.25%, signaling renewed investor interest following a 32% gain observed since late January.
Uniswap Surges 32% After Breakdown
On February 6, 2026, crypto analyst CryptoPulse pointed out the latest performance of UNI and emphasized how the recent 32% rally in the token compares to their previous technical predictions. CryptoPulse tweeted: On January 29, the head-and-shoulders pattern broke, suggesting further downside.
This signal was followed by investors who were able to take advantage of the price movement, thus emphasizing the need for technical analysis in this volatile DeFi market.
In addition, CryptoPulse noted that it is also vital for investors in Uniswap to understand the overall market trends, such as the shift in momentum, in order to take advantage of the market sentiment.
Also Read | Cronos Price Prediction 2026-2032: Will CRO Reach $1?
Bitwise Moves Forward With UNI ETF
Adding to the positive news, Bitwise Asset Management has officially filed its registration statement with the SEC for its proposed spot Uniswap (UNI) ETF.
The proposed ETF will track UNI directly, but there will be no staking involved. The custody of the assets of the proposed ETF will be provided by Coinbase Custody Trust Company.
According to market observers, the asset’s impressive performance in recent times, as well as the possibility of having a spot ETF, makes it likely that UNI could be one of the most watched tokens in the market in the next few weeks, with investors keen on observing support and resistance levels to ascertain whether the asset can sustain its performance.
Also Read | Injective (INJ) Holds Critical $3 Support; Relief Rally Could Reach $10 Soon
